期刊文献+

阿司匹林与氯吡格雷联用对短暂性脑缺血发作患者的疗效观察 被引量:1

Effect of Aspirin Combined with Clopidogrel on Patients with Transient Ischemic Attack
下载PDF
导出
摘要 目的探讨阿司匹林联合氯吡格雷治疗短暂性脑缺血发作的治疗效果。方法选取我院2014—2015年收治的100例短暂性脑缺血发作患者,按照随机数字表法分为观察组和对照组,各50例。两组中对合并高血压、2型糖尿病者采取常规对症治疗,对照组在常规对症治疗的基础上口服阿司匹林,观察组在对照组治疗基础上口服氯吡格雷,观察两组治疗效果。结果观察组总有效率88.0%,对照组总有效率60.0%,观察组总有效率明显高于对照组(P<0.05);治疗后观察组NIHSS评分明显低于对照组,差异有统计学意义(P<0.05);观察组复发率8.0%(4/50),脑梗死发生率2.0%(1/50),对照组复发率16.0%(8/50),脑梗死发生率10.0%(5/50),观察组均明显低于对照组(P<0.05)。结论阿司匹林联合氯吡格雷治疗短暂性脑缺血发作疗效显著,且可有效降低复发率。 Objective To investigate the effect of aspirin combined with clopidogrel on patients with transient ischemic attack (TIA). Methods 100 TIA patients, from January 2014 to December 2015, were selected and divided into control group and experiment group randomly. The conventional treatment was applied to the patients with hypertension or type 2 diabetes in the two groups. Based on this, the control group was given aspirin while the experimental group was given clopidogrel combined with aspirin. The curative effect and incidence of adverse reactions during treatment were observed. Results The total effective rate of the experimental group was 88% while the control group was 60%. The difference between the two groups was significant (P〈0. 05 ). After the treatment, the experimental group's NIHSS score was significantly lower than that in the control group (P〈0. 05 ). The recurrence rate and cerebral infarction incidence rate in the experimental group were significantly lower than that in the control group with the experimental group 8%, 2% and the control group 16%, 10%. (P 〈 0. 05). Conclusion Aspirin combined with clopidogrel has certain curative effect on the patients with transient ischemic attack and can effectively reduce the recurrence rate.
出处 《锦州医科大学学报》 CAS 2017年第1期43-45,共3页 Journal of Jinzhou Medical University
关键词 阿司匹林 氯吡格雷 短暂性脑缺血发作 疗效 aspirin clopidogrel transient ischemic attack effect
  • 相关文献

二级参考文献44

  • 1张冰,张晓玲,史江峰.依达拉奉联合葛根素注射液治疗急性脑梗塞的临床疗效观察[J].黑龙江医药,2009,22(6):865-866. 被引量:11
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33055
  • 3Steering Committee of the Physicians'Health Study Research Group. Final report on the aspirin component of the ongoing Physicians' Health Study[J]. N Engl J Med,1989,321:129 -135.
  • 4Ridker PM, Cook NR, Lee IM, et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women [ J]. N Engl J Med ,2005 ,352 : 1293 - 1304.
  • 5Hayden M, Pignone M, Phillips C, et al. Aspirin for the primary pre- vention of cardiovascular events : a summary of the evidence for the US Preventive Services Task Force[ J]. Ann Intern Med,2002,136: 161 - 172.
  • 6Berger JS, Roneaglioni Me, Avanzini F, et al. Aspirin for the primary prevention of cardiovascular events in women and mell : a sex-specif- ic meta-analysis of randomized controlled trials [ J ]. JAMA, 2006, 295:306 - 313.
  • 7Antithrombotic Trialists' ( ATr ) Collaboration, Baigent C, Blackwell L, et al. Aspirin in the primary and secondary prevention of vascular diverse: collaborative nleta-analysis of individual participant data from randomised trims[ J]. Lancet ,2009,373 : 1849 - 1860.
  • 8U. S. Preventive Services Task Force. Aspirin for the primry preven- tion of cardiovascular events: recommendation andrational [ J ]. Ann Intern Med,2002,136 (2) : 157 - 160.
  • 9U. S. Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: US Preventive Services Task Force recom- mendation statement [ J ]. Ann Intern Med, 2009,150 : 396 - 404.
  • 10Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories [ J ]. Circulation, 1998,97: 1837 - 1847.

共引文献78

同被引文献32

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部